StockData
Nektar Therapeutics logo

Nektar Therapeutics (NKTR) stock

NKTRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 9/30
$34.42−1.49 (-4.15%)

Close on Nov 18, 2026Market cap $1.18BP/E –Yield –

Nektar Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Nektar Therapeutics's price to book ratio was 0.9× on Nov 11, 2026, against 15.1× a year earlier. Over the last 5 years it ranged from 0.4× to 23.3×, with a median of 1.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−8.9
2025Dec 31, 20259.8×+6.3
2024Dec 31, 20243.5×+2.8
2023Dec 29, 20230.7×−0.4
2022Dec 30, 20221.0×−2.1
2021Dec 31, 20213.1×+0.5
2020Dec 31, 20202.6×+0.1
2019Dec 31, 20192.5×−0.6
2018Dec 31, 20183.2×−108.2
2017Dec 29, 2017111.4×−218.6
2016Apr 29, 2016330.0×+272.5
2015Dec 31, 201557.5×+15.4
2014Dec 31, 201442.1×+15.5
2013Apr 30, 201326.6×+17.6
2012Dec 31, 20128.9×+6.2
2011Dec 30, 20112.8×–

More Nektar Therapeutics figures

See a number that looks wrong?